Effect of Ramadan Fasting on Chronic Inflammation and Body Composition in Patients with Chronic Kidney Disease.

Saudi J Kidney Dis Transpl

Department of Internal Medicine, Nephrology and Dialysis Unit, Mansoura University, Mansoura, Egypt.

Published: March 2022

Chronic kidney disease (CKD) is associated with a state of chronic inflammation which is responsible for many of the pathophysiological changes detected in these patients. Many studies have evaluated the effect of Ramadan fasting on renal function and cardiovascular morbidity in CKD patients, but the effect of Ramadan fasting on markers of chronic inflammation was not previously assessed. This study aimed to evaluate the effect of Ramadan fasting on some markers of chronic inflammation in CKD patients with estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73 m body surface area and not on dialysis. This was a pilot study that included 20 patients (8 males and 12 females), mean age 61.9 years with CKD (eGFR <60 mL/min/1.73 m body surface area not on dialysis) who fasted the whole lunar month of Ramadan. Complete blood count, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), high-sensitive C-reactive protein (hs-CRP), serum creatinine (SCr), eGFR, serum albumin, body weight, body mass index (BMI), and body composition assessed by bioimpedance analysis were assessed before and after Ramadan fasting. Ramadan fasting was not associated with significant change of SCr (P = 0.132), eGFR (P = 0.097), serum albumin (P = 0.352), body weight (P = 0.445), BMI (P = 0.168), body fat (P = 0.979), visceral fat (P = 0.163), muscle mass (P = 0.662), or body water (P = 0.815). There was a statistically significant decrease of markers of chronic inflammation including NLR (P = 0.003), PLR (P = 0.005), and hs-CRP (P = 0.000) after Ramadan fasting. Ramadan fasting was associated with improvement of the state of chronic inflammation in CKD patients (eGFR below 60 mL/min/1.73 m body surface area). Ramadan fasting was not associated with a significant change of body composition or deterioration of renal function tests in CKD patients.

Download full-text PDF

Source
http://dx.doi.org/10.4103/1319-2442.338274DOI Listing

Publication Analysis

Top Keywords

ramadan fasting
16
chronic inflammation
16
chronic kidney
8
kidney disease
8
ckd patients
8
fasting markers
8
markers chronic
8
chronic
6
patients
5
ramadan
4

Similar Publications

Fasting during Ramadan involves abstaining from food and drink from dawn to dusk for 29 to 30 days, annually. Dietitians, experts in food and nutrition, play a vital role in fostering the well-being of Canadians. Given that 1 in 20 Canadians are Muslim, access to culturally safe care is essential for their health.

View Article and Find Full Text PDF

Ramadan is a month-long religious festival observed by Muslim worldwide, characterised by intermittent fasting. This qualitative study addressed the need to understand how fasting is experienced by Muslims residing in Western cultures, aiming to inform policies that create a more supportive environment. Practicing Muslims, both men and women, were recruited in the North of England in the United Kingdom (UK).

View Article and Find Full Text PDF

Impacts of Ramadan fasting during pregnancy on pregnancy and birth outcomes: An umbrella review.

Int J Gynaecol Obstet

January 2025

Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee, USA.

Background: Despite a large number of primary research studies, and systematic and narrative reviews, there is no consensus on the impact of fasting during Ramadan while pregnant on pregnancy and birth outcomes. Currently, there is no evidence-based guideline for Muslim women regarding Ramadan fasting during pregnancy and clinicians cannot provide firm recommendations.

Objectives: To review the current evidence regarding the impact of Ramadan fasting during pregnancy on pregnancy and birth outcomes.

View Article and Find Full Text PDF

Insulin resistance and diabetes are associated with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) conditions, which are distinguished by metabolic dysfunction, oxidative stress and inflammation. Sirtuin 1 (SIRT1), a NAD-dependent deacetylase, is fundamental in regulating metabolic pathways, reducing inflammation, and improving antioxidant defenses. This is the first study to investigate the effects of SRT1720, a SIRT1 activator, in diabetic rats on a high-fat diet.

View Article and Find Full Text PDF

Background/objectives: Fasting, orthorexia nervosa, and eating disorders are increasingly prevalent and interconnected. Understanding their relationship is essential for identifying potential risks and developing effective prevention and intervention strategies. This study investigated these associations to enhance our knowledge of their interplay and implications for mental health.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!